Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA

Genome Research

Volumn 24, Issue 6, 2014, Pages 1020-1027

  Ramakrishna, Suresh ^a   Kwaku Dad, Abu Bonsrah ^a   Beloor, Jagadish ^a   Gopalappa, Ramu ^a   Lee, Sang Kyung ^a   Kim, Hyongbum ^a  

^a Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAS9 PROTEIN; CELL PENETRATING PEPTIDE; ENDONUCLEASE; RECOMBINANT PROTEIN; RNA GUIDED ENDONUCLEASE; UNCLASSIFIED DRUG; GUIDE RNA; NANOPARTICLE;

ARTICLE; CONJUGATION; DNA CLEAVAGE; EMBRYONIC STEM CELL; GENE DISRUPTION; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO GENE TRANSFER; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN RNA BINDING; SKIN FIBROBLAST; CHEMISTRY; CRISPR CAS SYSTEM; GENETIC TRANSFECTION; GENETICS; HUMAN GENOME; PROCEDURES; RNA EDITING; SITE DIRECTED MUTAGENESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; CRISPR-CAS SYSTEMS; GENOME, HUMAN; HEK293 CELLS; HUMANS; MUTAGENESIS, SITE-DIRECTED; NANOPARTICLES; RNA EDITING; RNA, GUIDE; TRANSFECTION;

EID: 84901843996     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.171264.113     Document Type: Article

References (45)

1. Budman J, Chu G. 2005. Processing of DNA for nonhomologous endjoining by cell-free extract. EMBO J 24: 849-860. (Pubitemid 40396113)
2. Cho SW, Kim S, Kim JM, Kim JS. 2013a. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31: 230-232.
3. Cho SW, Lee J, Carroll D, Kim JS. 2013b. Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics 195: 1177-1180.
4. Cho SW, Kim S, Kim Y, Kweon J, Kim HS, Bae S, Kim JS. 2014. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res 24: 132-141.
5. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823.
6. Dickinson DJ, Ward JD, Reiner DJ, Goldstein B. 2013. Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat Methods 10: 1028-1034.
7. Ding H, Inoue S, Ljubimov AV, Patil R, Portilla-Arias J, Hu J, Konda B, Wawrowsky KA, Fujita M, Karabalin N, et al. 2010. Inhibition of brain tumor growth by intravenous poly (b-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected]. Proc Natl Acad Sci 107: 18143-18148.
8. Friedland AE, Tzur YB, Esvelt KM, Colaiacovo MP, Church GM, Calarco JA. 2013. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods 10: 741-743.
9. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD. 2013. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31: 822-826.
10. Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK. 2014. Improving CRISPRCas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32: 279-284.
11. Gaj T, Guo J, Kato Y, Sirk SJ, Barbas CF III. 2012. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods 9: 805-807.
12. Gratz SJ, Cummings AM, Nguyen JN, Hamm DC, Donohue LK, Harrison MM, Wildonger J, O'Connor-Giles KM. 2013. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 194: 1029-1035.
13. Guschin DY, Waite AJ, Katibah GE, Miller JC, Holmes MC, Rebar EJ. 2010. A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol 649: 247-256.
14. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745. (Pubitemid 32015992)
15. Horvath P, Barrangou R. 2010. CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167-170.
16. Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, et al. 2013.DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31: 827-832.
17. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, Joung JK. 2013. Efficient genome editing in zebrafish using a CRISPRCas system. Nat Biotechnol 31: 227-229.
18. Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. 2013. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31: 233-239.
19. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
20. Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. 2013. RNA-programmed genome editing in human cells. Elife 2: e00471.
21. Kim HJ, Lee HJ, Kim H, Cho SW, Kim JS. 2009. Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. Genome Res 19: 1279-1288.
22. Kim H, Um E, Cho SR, Jung C, Kim JS. 2011. Surrogate reporters for enrichment of cells with nuclease-induced mutations. Nat Methods 8: 941-943.
23. Kim H, Kim MS, Wee G, Lee CI, Kim JS. 2013. Magnetic separation and antibiotics selection enable enrichment of cells with ZFN/TALEN-induced mutations. PLoS ONE 8: e56476.
24. Kim S, Kim D, Cho SW, Kim J, Kim JS. 2014. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res (this issue). doi: 10.1101/gr.171322.113.
25. Li D, Qiu Z, Shao Y, Chen Y, Guan Y, Liu M, Li Y, Gao N, Wang L, Lu X, et al. 2013a. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol 31: 681-683.
26. Li JF, Norville JE, Aach J, McCormack M, Zhang D, Bush J, Church GM, Sheen J. 2013b. Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nat Biotechnol 31: 688-691.
27. Li W, Teng F, Li T, Zhou Q. 2013c. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol 31: 684-686.
28. Liu J, Gaj T, Patterson JT, Sirk SJ, Barbas Iii CF. 2014. Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering. PLoS ONE 9: e85755.
29. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339: 823-826.
30. Matsui H, Tomizawa K, Lu YF, Matsushita M. 2003. Protein therapy: in vivo protein transduction by polyarginine (11R) PTD and subcellular targeting delivery. Curr Protein Pept Sci 4: 151-157. (Pubitemid 36834014)
31. Nakase I, Tanaka G, Futaki S. 2013. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells. Mol Biosyst 9: 855-861.
32. Nekrasov V, Staskawicz B, Weigel D, Jones JD, Kamoun S. 2013. Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nat Biotechnol 31: 691-693.
33. Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. 2013. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol 31: 839-843.
34. Ramakrishna S, Kim YH, Kim H. 2013. Stability of zinc finger nuclease protein is enhanced by the proteasome inhibitor MG132. PLoS ONE 8: e54282.
35. Ramakrishna S, Cho SW, Kim S, Song M, Gopalappa R, Kim JS, Kim H. 2014. Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations. Nat Commun 5: 3378.
36. Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, et al. 2013. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154: 1380-1389.
37. Regberg J, Eriksson JN, Langel U. 2013. Cell-penetrating peptides: from cell cultures to in vivo applications. Front Biosci 5: 509-516.
38. Shan Q, Wang Y, Li J, Zhang Y, Chen K, Liang Z, Zhang K, Liu J, Xi JJ, Qiu JL, et al. 2013. Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol 31: 686-688.
39. Shen B, Zhang W, Zhang J, Zhou J, Wang J, Chen L, Wang L, Hodgkins A, Iyer V, Huang X, et al. 2014. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods 11: 399-402.
40. Sung YH, Kim JM, Kim HT, Lee J, Jeon J, Jin Y, Choi JH, Ban YH, Ha SJ, Kim CH, et al. 2014. Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. Genome Res 24: 125-131.
41. Vasconcelos L, Parn K, Langel U. 2013. Therapeutic potential of cell-penetrating peptides. Ther Deliv 4: 573-591.
42. Wagner H. 2001. Toll meets bacterial CpG-DNA. Immunity 14: 499-502. (Pubitemid 32520861)
43. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. 2013.One-step generation ofmice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153: 910-918.
44. Wiedenheft B, Sternberg SH, Doudna JA. 2012. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482: 331-338.
45. Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R. 2013. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154: 1370-1379.